Xin Wei Wang
#149,428
Most Influential Person Now
Researcher
Xin Wei Wang's AcademicInfluence.com Rankings
Xin Wei Wangengineering Degrees
Engineering
#5985
World Rank
#7275
Historical Rank
Electrical Engineering
#1723
World Rank
#1821
Historical Rank
Xin Wei Wangcomputer-science Degrees
Computer Science
#7747
World Rank
#8152
Historical Rank
Computational Linguistics
#1611
World Rank
#1628
Historical Rank
Machine Learning
#2970
World Rank
#3007
Historical Rank
Artificial Intelligence
#3266
World Rank
#3314
Historical Rank
Download Badge
Engineering Computer Science
Xin Wei Wang's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Xin Wei Wang Influential?
(Suggest an Edit or Addition)Xin Wei Wang's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. (2009) (1092)
- Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning (2003) (816)
- Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. (2006) (782)
- Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. (2008) (759)
- A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. (2010) (755)
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells (2018) (732)
- Identification of metastasis‐related microRNAs in hepatocellular carcinoma (2008) (726)
- EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. (2008) (687)
- Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. (1994) (670)
- GADD45 induction of a G2/M cell cycle checkpoint. (1999) (652)
- MicroRNA expression, survival, and response to interferon in liver cancer. (2009) (643)
- p53 modulation of TFIIH–associated nucleotide excision repair activity (1995) (590)
- Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells (2009) (530)
- TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer (2007) (529)
- Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 (1999) (503)
- SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. (2011) (466)
- Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. (1996) (453)
- MicroRNAs in liver disease. (2012) (451)
- Cancer stem cells in the development of liver cancer. (2013) (440)
- Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. (2007) (433)
- MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival (2009) (390)
- The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. (1996) (352)
- Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression. (2016) (332)
- Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. (1997) (323)
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer. (2019) (314)
- The role of cytokines in hepatocellular carcinoma (2006) (295)
- Temporal and spatial control of nucleophosmin by the Ran–Crm1 complex in centrosome duplication (2005) (294)
- Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. (2012) (290)
- Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. (2017) (256)
- TP53 and liver carcinogenesis (2003) (236)
- Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. (1995) (235)
- Necroptosis microenvironment directs lineage commitment in liver cancer (2018) (228)
- Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma (2013) (223)
- Interaction of p53 with the human Rad51 protein. (1997) (223)
- Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma (2007) (210)
- Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma (2012) (206)
- Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. (2010) (201)
- DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53 (2001) (197)
- Clinical implications of cancer stem cell biology in hepatocellular carcinoma. (2012) (194)
- Sal‐like protein 4 (SALL4), a stem cell biomarker in liver cancers (2013) (190)
- p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. (2003) (186)
- Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer (2010) (184)
- Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. (2013) (184)
- Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. (1991) (183)
- p53-mediated apoptosis is attenuated in Werner syndrome cells. (1999) (181)
- Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma (2018) (181)
- The RGG domain in hnRNP A2 affects subcellular localization. (2000) (181)
- Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene. (2000) (177)
- Hepatitis B virus X protein inhibits nucleotide excision repair (1999) (171)
- Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances (2019) (157)
- Involvement of Crm1 in Hepatitis B Virus X Protein-Induced Aberrant Centriole Replication and Abnormal Mitotic Spindles (2003) (155)
- Functional Interaction of p53 and BLM DNA Helicase in Apoptosis* (2001) (152)
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma (2013) (148)
- Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches (2015) (147)
- Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells (2011) (145)
- GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. (2016) (144)
- Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes. (2019) (140)
- Cancer‐associated molecular signature in the tissue samples of patients with cirrhosis (2004) (137)
- Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. (2007) (135)
- A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions (2012) (133)
- The significance of intertumor and intratumor heterogeneity in liver cancer (2018) (132)
- Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin (2000) (131)
- Defective Interplay of Activators and Repressors with TFIIH in Xeroderma Pigmentosum (2001) (130)
- The Processing of Holliday Junctions by BLM and WRN Helicases Is Regulated by p53* 210 (2002) (130)
- Conformation-dependent phosphorylation of p53. (1997) (126)
- Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma (2011) (125)
- Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. (2011) (125)
- Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. (1995) (120)
- Molecular pathogenesis of human hepatocellular carcinoma. (2002) (119)
- Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma (2015) (118)
- Genetic toxicology of lead compounds. (1988) (115)
- Nucleophosmin and human cancer. (2006) (114)
- The clinical potential of microRNAs (2010) (113)
- Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma (2013) (109)
- p53 tumor‐suppressor gene: Clues to molecular carcinogenesis (1997) (105)
- The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. (2005) (105)
- Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma. (2017) (102)
- Sixty‐five gene‐based risk score classifier predicts overall survival in hepatocellular carcinoma (2012) (101)
- p53 Modulates the Exonuclease Activity of Werner Syndrome Protein* (2001) (99)
- Regulation of gene expression by the BLM helicase correlates with the presence of G-quadruplex DNA motifs (2014) (98)
- Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? (2011) (98)
- Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis (2001) (94)
- Distinctive gene expression profiles associated with Hepatitis B virus x protein (2001) (94)
- Interaction of the Hepatitis B Virus X Protein with the Crm1-dependent Nuclear Export Pathway* (2001) (94)
- Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma (2018) (92)
- Identification of a Functional Domain in a GADD45-mediated G2/M Checkpoint* (2000) (90)
- Genomic Predictors for Recurrence Patterns of Hepatocellular Carcinoma: Model Derivation and Validation (2014) (87)
- Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines. (1986) (86)
- Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. (2017) (85)
- New kids on the block: Diagnostic and prognostic microRNAs in hepatocellular carcinoma (2009) (80)
- Regulatory MiR‐148a‐ACVR1/BMP circuit defines a cancer stem cell‐like aggressive subtype of hepatocellular carcinoma (2015) (78)
- Modulation of miR‐29 expression by alpha‐fetoprotein is linked to the hepatocellular carcinoma epigenome (2014) (78)
- Identification, functional characterization, and chromosomal localization of USP15, a novel human ubiquitin-specific protease related to the UNP oncoprotein, and a systematic nomenclature for human ubiquitin-specific proteases. (1999) (77)
- The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase (2004) (75)
- Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. (2019) (75)
- Tissue‐specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral‐mediated transfer of the wild‐type p53 gene (1996) (68)
- Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma (2016) (67)
- Inflammatory and MicroRNA Gene Expression as Prognostic Classifier of Barrett's-Associated Esophageal Adenocarcinoma (2010) (65)
- Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? (2003) (64)
- Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival (2018) (63)
- Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death (1999) (63)
- Role of p53 and apoptosis in carcinogenesis. (1999) (62)
- Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. (2021) (62)
- Effect of magnesium on nickel-induced genotoxicity and cell transformation. (1987) (58)
- Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis (2015) (56)
- The Molecular Signature of Metastases of Human Hepatocellular Carcinoma (2005) (56)
- Gut microbiome directs hepatocytes to recruit MDSC and promote cholangiocarcinoma. (2020) (55)
- Mesothelin as a Potential Therapeutic Target in Human Cholangiocarcinoma (2010) (53)
- CD40-mediated immune cell activation enhances response to anti-PD1 in murine intrahepatic cholangiocarcinoma. (2020) (52)
- Identification of microRNAs specific for epithelial cell adhesion molecule–positive tumor cells in hepatocellular carcinoma (2015) (50)
- microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma (2013) (50)
- Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide (2016) (48)
- Integrative Genomics Identifies YY1AP1 as an Oncogenic Driver in EpCAM+ AFP+ Hepatocellular Carcinoma (2014) (47)
- Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma (2021) (47)
- Identification of Drivers from Cancer Genome Diversity in Hepatocellular Carcinoma (2014) (45)
- Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression (2015) (44)
- TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy. (1996) (43)
- The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma (2021) (43)
- COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis. (1999) (42)
- Cooperation of tumor‐derived HBx mutants and p53‐249ser mutant in regulating cell proliferation, anchorage‐independent growth and aneuploidy in a telomerase‐immortalized normal human hepatocyte‐derived cell line (2009) (40)
- WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer. (2007) (39)
- Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain. (1999) (39)
- Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth (2017) (38)
- Integrative Genomic and Transcriptomic Characterization of Matched Primary and Metastatic Liver and Colorectal Carcinoma (2015) (37)
- Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. (2007) (37)
- PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma (2020) (37)
- A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer (2016) (36)
- The genomic landscape of Mongolian hepatocellular carcinoma (2020) (36)
- Depletion of TRRAP Induces p53‐Independent Senescence in Liver Cancer by Down‐Regulating Mitotic Genes (2020) (36)
- SAGE transcript profiles of normal primary human hepatocytes expressing oncogenic hepatitis B virus X protein (2002) (36)
- A conserved region in human and Chinese hamster X chromosomes can induce cellular senescence of nickel-transformed Chinese hamster cell lines. (1992) (35)
- Molecular pathogenesis and systemic therapies for hepatocellular carcinoma (2022) (35)
- A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma (2020) (35)
- Studies on the relationship between protein kinase C and differentiation of human promyelocytic leukemia cells induced by retinoic acid. (1989) (33)
- Effect of Hepatitis C Virus Core Protein on the Molecular Profiling of Human B Lymphocytes (2006) (32)
- Understanding tumor cell heterogeneity and its implication for immunotherapy in liver cancer by single cell analysis. (2020) (31)
- The biological and clinical challenge of liver cancer heterogeneity. (2014) (31)
- A Yin-Yang balancing act of the lin28/let-7 link in tumorigenesis. (2010) (29)
- MiR‐125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma (2020) (29)
- Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin‐6 signaling in hepatocellular carcinoma (2016) (27)
- Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma (2013) (26)
- Translating the Metastasis Paradigm from Scientific Theory to Clinical Oncology (2009) (25)
- Metabolic Profiles are Principally Different between Cancers of the Liver, Pancreas and Breast (2014) (25)
- Redundancy of DNA helicases in p53-mediated apoptosis (2006) (24)
- Intratumoral γδ T-cell infiltrates, CCL4/5 protein expression and survival in patients with hepatocellular carcinoma. (2020) (20)
- Future of molecular profiling of human hepatocellular carcinoma. (2007) (20)
- Metformin treatment rescues CD8+ T cell response to immune checkpoint inhibitor therapy in mice with NAFLD. (2022) (20)
- Understanding the Cause and Consequence of Tumor Heterogeneity. (2020) (19)
- Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis. (2021) (18)
- Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference. (2005) (18)
- p53 and p14 Increase Sensitivity of Gastric Cells to H. Pylori-Induced Apoptosis (2003) (18)
- Abstract 5183: Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome (2014) (17)
- Characterization of mouse cell lines resistant to nickel(II) ions. (1988) (17)
- microRNA Regulation and Its Consequences in Cancer (2013) (17)
- Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma. (2019) (16)
- LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours (2015) (16)
- p53: at the crossroads of molecular carcinogenesis and molecular epidemiology. (2004) (16)
- Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression (2017) (16)
- Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis (2018) (15)
- Transcriptome analysis of liver cancer: ready for the clinic? (2009) (15)
- MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs. (2021) (15)
- High‐throughput Screening for Identification of Inhibitors of EpCAM‐Dependent Growth of Hepatocellular Carcinoma Cells (2013) (14)
- Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans (2006) (14)
- Identification of cancer stem cell-related microRNAs in hepatocellular carcinoma. (2012) (13)
- PG25, a pineal-specific cDNA, cloned by differential display PCR (DDPCR) and rapid amplification of cDNA ends (RACE) (1997) (13)
- Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma (2020) (13)
- Roles of mitochondria in liver cancer stem cells. (2019) (13)
- Intratumoral γδ T‐Cell Infiltrates, Chemokine (C‐C Motif) Ligand 4/Chemokine (C‐C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma (2021) (13)
- Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers (2020) (13)
- Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization (2019) (12)
- Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma (2019) (12)
- Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma (2020) (11)
- Molecular genetics of liver neoplasia (2011) (11)
- Identification of genomic functional hotspots with copy number alteration in liver cancer (2013) (11)
- Functional Genomic Complexity Defines Intratumor Heterogeneity and Tumor Aggressiveness in Liver Cancer (2019) (11)
- Transforming the microenvironment: a trick of the metastatic cancer cell. (2012) (11)
- NMR Characterization of Rearranged Staurosporine Aglycone Analogues from the Marine Sponge Damiria sp. (2019) (11)
- Impact of Next-Generation Sequencing on Outcomes in Hepatocellular Carcinoma: How Precise Are We Really? (2020) (10)
- The status of transarterial chemoembolization treatment in the era of precision oncology. (2017) (10)
- The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis. (2022) (10)
- Cell cycle-dependent phosphorylation of nucleophosmin and its potential regulation by peptidyl-prolyl cis/trans isomerase. (2015) (10)
- iSubgraph: Integrative Genomics for Subgroup Discovery in Hepatocellular Carcinoma Using Graph Mining and Mixture Models (2013) (10)
- Deciphering cancer heterogeneity: the biological space (2014) (9)
- The origin of cancer stem cells. (2014) (9)
- AGO2 Mediates MYC mRNA Stability in Hepatocellular Carcinoma (2020) (8)
- Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome‐wide association study (2021) (8)
- Power play: scoring our goals for liver cancer with better GWAS study design. (2011) (7)
- The basic-helix-loop-helix-leucine zipper gene Mitf: analysis of alternative promoter choice and splicing. (2010) (7)
- NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma (2019) (7)
- MicroRNAs in Hepatocellular Carcinoma (2011) (6)
- Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma (2019) (6)
- The evolving landscape of precision medicine in primary liver cancer (2019) (6)
- Interactive Effects of p53 Tumor Suppressor Gene and Hepatitis B Virus in Hepatocellular Carcinogenesis (1997) (6)
- The search for precision models clinically relevant to human liver cancer. (2015) (5)
- Single-cell atlas of tumor clonal evolution in liver cancer (2020) (5)
- Proteomic heterogeneity reveals SOAT1 as a potential biomarker for hepatocellular carcinoma. (2019) (5)
- Nitric oxide-induced p 53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p 53 ( tumor suppressor gene / mutagenesis / carcinogenesis ) (2005) (5)
- Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2 (2020) (5)
- Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis (2021) (4)
- Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling (2022) (4)
- Molecular Carcinogenesis of HBV-Related HCC (2018) (3)
- Interacts with hRAD 51 and hRAD 54 , and Directly Modulates Homologous Recombination 1 , 2 (2003) (3)
- Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. (2019) (3)
- MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression. (2023) (3)
- MS.liverK: an R package for transcriptome-based computation of molecular subtypes and functional signatures in liver cancer (2019) (3)
- Translating bioinformatics in oncology: Guilty by profiling meta-analysis and identification of KIF18B and CDCA3 as novel driver genes in liver carcinogenesis (2013) (3)
- Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer (2018) (3)
- Creatine riboside is a cancer cell–derived metabolite associated with arginine auxotrophy (2022) (3)
- Interleukin-27 signaling serves as an immunological checkpoint for innate cytotoxic cells to promote hepatocellular carcinoma. (2022) (3)
- Alteration of nickel-binding proteins in nickel-resistant cells. (1989) (2)
- Abstract A02: Gut microbiome controls growth of liver tumors (2018) (2)
- Abstract 3143: A functional interaction between alpha-fetoprotein and miRNA-29 modulates the HCC epigenome. (2013) (2)
- Overview of Cholangiocarcinoma and Evidence for a Primary Liver Carcinoma Spectrum (2010) (2)
- Abstract SY11-01: Knockout mouse models for sirtuins: Genome integrity, metabolism, and cancer (2011) (2)
- Abstract 3003: Immune cell-related microRNA-155 is associated with human liver cirrhosis and hepatocellular carcinoma (2010) (2)
- Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer (2022) (2)
- Single‐cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC (2022) (2)
- Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution (2021) (2)
- Necroptosis microenvironment directs lineage commitment in liver cancer (2018) (2)
- Stiff matrix induces exosome secretion to promote tumour growth (2023) (2)
- Immunology and immunotherapy of cholangiocarcinoma. (2023) (2)
- Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report. (2021) (1)
- Abstract 2975: Transgenic mouse model of Twist1-induced metastasis reveals genes highly prognostic for human hepatocellular carcinoma (2012) (1)
- Abstract 936: Single cell analysis reveals cancer stem cell heterogeneities in hepatocellular carcinoma (2017) (1)
- Abstract 544: Hypoxia response signaling is linked to TACE resistance in hepatocellular carcinoma (HCC) patients (2017) (1)
- Abstract LB-173: The Thailand initiative in genomics and expression research for liver cancer (TIGER-LC): Defining novel subtypes of hepatocellular carcinoma and cholangiocarcinoma (2015) (1)
- Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma (2021) (1)
- A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML) for patients with hepatic malignancies. (2007) (1)
- Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2 (2022) (1)
- Molecular Signatures of Hepatocellular Carcinoma Metastasis (2010) (1)
- [A laboratory and clinical study of induced differentiation therapy by all trans-retinoic acid in acute promyelocytic leukemia]. (1992) (1)
- Molecular Profiling of Human Hepatocellular Carcinoma (2016) (1)
- Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer (2022) (1)
- Inflammation and human cancer (2008) (1)
- Biology of Hepatocellular Carcinoma: Past, Present and Beyond (2010) (1)
- Genome-based predictors for HCC outcomes: a matter of tumor and/or stroma. (2009) (1)
- Identification of MicroRNAs Specific for EpCAM + Tumor Cells in Hepatocellular Carcinoma (2015) (1)
- A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma. (2022) (1)
- Abstract 360: Senescent hepatocytes secrete CCL2 to accelerate liver cancer growth via accumulation of immunosuppressive myeloid cells (2015) (1)
- Abstract 4391: Identification of novel cancer driver genes in hepatocellular carcinoma cells by RNAi screening method (2017) (1)
- MicroRNAs and Gastroenterological Cancers. (2011) (1)
- Abstract 2759: USP21 stabilizes the BRCA2/Rad51 complex to ensure cancer genome maintenance (2016) (0)
- Abstract 1500: Understanding tumor cell community and its evolution by single cell analysis in liver cancer (2020) (0)
- Abstract 1985: Oncogenic activation of RNA binding proteins and c-Myc signaling in hepatocellular carcinoma (2016) (0)
- Abstract IA40: Race-related liver tumor subtypes are associated with gut microbiome-mediated metabolism (2020) (0)
- Comprar Molecular Genetics of Liver Neoplasia | Wang, Xin Wei | 978-1-4419-608189781441960818 | Springer (2011) (0)
- The p53 Family Gene Signature Predicts Prognosis in Hepatocellular Carcinoma (2013) (0)
- Hepatitis B vaccine and multiple sclerosis : A case of repeated déjà vu ? (2009) (0)
- Abstract 2402: Tid1 deficiency disrupting mitochondria to drive NASH-dependent hepatocellular carcinoma progression (2021) (0)
- Running title: Serum MDK in Diagnosis of HCC (2013) (0)
- Tumor suppressive mechanisms in hepatocellular carcinoma through inhibition of IL-6 signaling (2014) (0)
- Methods to determine the subtype of hepatocellular carcinoma (2008) (0)
- Abstract 5855: The genomic landscape of Mongolian hepatocellular carcinoma (2020) (0)
- MYC determines lineage commitment in kras driven primary liver cancer development. (2023) (0)
- Abstract 1404: A functional genetic polymorphism of mitochondrion-associated DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma (2023) (0)
- Targeting heterogeneity in hepatocellular carcinoma (0)
- Genome‐Wide Expression Profiling of Human Hepatocellular Carcinoma (2009) (0)
- Molecular Carcinogenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma (2021) (0)
- At the cancer steering wheel: defining key genomic drivers of liver cancer with next generation sequencing. (2012) (0)
- The importance of integrated genomics to uncover clinically relevant cancer driver genes (2016) (0)
- Prognostic Subtypes of Hepatocellular Carcinoma-Fetoprotein Expression Defines Novel α EpCAM and Updated (2008) (0)
- Exploration of Cytokine Signaling in Clinical Management of Hepatocellular Carcinoma (2012) (0)
- Diabetes-Associated Breast Cancer Is Molecularly Distinct and Shows DNA Repair Deficiency (2023) (0)
- REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012) (0)
- Hsps expression in three human glioma cell lines after radio-frequency field exposure (2008) (0)
- Reply: (2009) (0)
- Abstract A25: Array‐based comparative genomic hybridization of hepatocellular carcinoma reveals a unique genomic aberration pattern in tumors with poor prognosis (2009) (0)
- Abstract 2658: Oncogenicity of adeno-associated virus (AAV) integration into the genomes of liver cancer patients depends on the overlap between the AAV integration site and the AAV X gene (2021) (0)
- Abstract 2500: Urinary metabolites are diagnostic biomarkers of liver cancer (2017) (0)
- Abstract IA23: Molecular landscapes of hepatocellular carcinoma and cholangiocarcinoma (2022) (0)
- Abstract PR06: Identifying regulatory transcription factors in primary liver cancer cell lineage commitment using single cell ATAC sequencing (2022) (0)
- Correlation of cyclooxygenase‐2 expression with hypoxia in non‐small cell lung cancer (2007) (0)
- Abstract PR04: Understanding tumor clonal evolution by single-cell transcriptomic analysis in liver cancer (2020) (0)
- A compendium of co-regulated mitoribosomal proteins in pan-cancer uncovers collateral defective events in tumor malignancy (2022) (0)
- A new French paradox: HBV vaccination (2009) (0)
- Identification of Common Molecular Subtypes of Asian Hepatocellular Carcinoma and Cholangiocarcinoma. (2017) (0)
- Abstract 272: Identification of MicroRNAs unique to cancer stem cells by small RNA deep sequencing. (2013) (0)
- Causes and functional intricacies of inter- and intratumor heterogeneity of primary liver cancers. (2022) (0)
- NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma (2019) (0)
- Abstract 5336: Distinct liver cancer stem cells defined by EpCAM and CD90 in human hepatocellular carcinoma (2012) (0)
- A STUDY OF MOLECULAR AND GENETIC FACTORS FOR LIVER CANCER IN THE GREATER BALTIMORE AREA Abbreviated title: Biomarkers for Liver Cancer Principal Investigator and Affiliation (2017) (0)
- Using the miR-26 family as a predictive marker of hepatocellular carcinoma and sensitivity to therapy (2009) (0)
- Isolation and structure elucidation of bioactive leads from terrestrial plants (2014) (0)
- Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma via m6A-mediated epitranscriptomic regulation. (2023) (0)
- Differential gene expression in human primary hepatocytes regulated by the oncogenic hepatitis B virus X protein (2000) (0)
- scRNA-seq analysis of colon and esophageal tumors uncovers abundant microbial reads in myeloid cells undergoing proinflammatory transcriptional alterations (2023) (0)
- Dissecting Intratumor Heterogeneity in HCC: New Research Strategies & Clinical Implications. (2022) (0)
- Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer (2018) (0)
- Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival (2018) (0)
- PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma (2020) (0)
- The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases (2023) (0)
- 584 Cooperating Tumor Suppressor Genes on Chromosome 8p Predict Survival Outcome in Hepatocellular Carcinoma (2012) (0)
- Genomics Studies in Hepatocellular Carcinoma via Next-Generation Sequencing (2018) (0)
- Novel Tumour Suppressor Genes Sorbs3 and Sh2d4a Repress Il-6 Signalling in Hepatocellular Carcinoma (2016) (0)
- Abstract 6057: Association of liver cancer and chronic liver disease with urinary glyphosate and its metabolites in Thailand (2023) (0)
- Abstract 5767: Pan-viral response in African Americans and European Americans with hepatocellular carcinoma (2023) (0)
- Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis (2021) (0)
- Abstract 1983: TP53 mutations in hepatocellular carcinoma: Association with survival and stem cell-like gene expression traits (2010) (0)
- Liver, Pancreas, and Biliary Tract 肝疾患とMicroRNAs (2012) (0)
- Abstract 4818: Validation and clinical utility of a human hepatocellular carcinoma metastasis signature as prognostic classifier (2010) (0)
- Molecular and Cellular Pathobiology A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients (2010) (0)
- Abstract 3156: Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer (2019) (0)
- Pathway analysis of metabolic genes and serum metabolites in HCC reveal aberrations associated with fatty acid and lipid metabolism (2018) (0)
- Abstract 4468: Oncogenic activation of the RNA binding protein AGO2 in hepatocellular carcinoma (2017) (0)
- THU-491-The role of alanine glyoxylate aminotransferase in hepatocellular carcinoma (2019) (0)
- Molecular chaperone HSP90 regulation of the alternative splicing of numb as a clue for HCC progression. (2014) (0)
- Abstract 4390: The Thailand initiative in genomics and expression research in liver cancer: Race related common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma identified by integrated genomics (2017) (0)
- Mo1435 – Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer (2019) (0)
- Abstract C20: The epigenomic fingerprint of hepatocellular carcinoma (2011) (0)
- Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma (2020) (0)
- Abstract 2030: Wnt/beta-catenin signaling acts as a master regulator of microRNA-181 expression in hepatocellular carcinoma (2010) (0)
- Genomic Profiling of Human Hepatocellular Carcinoma (2009) (0)
- Oncogenic NELFE Enhances MYC-induced Hepatocellular Carcinogenesis (2017) (0)
- Abstract LB-408: An integrative genomic approach uncovers oncogenic roles of YY1-signaling in hepatocellular carcinoma with stem cell-like traits (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Xin Wei Wang?
Xin Wei Wang is affiliated with the following schools:
